Virtual Reality for Delirium After Surgery

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: The Methodist Hospital Research Institute

Must not be taking: Antipsychotics

Disqualifiers: Cognitive impairment, Psychiatric disorders, Deaf, Blind, Seizure disorders, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

Duration: Up to 2 hours per session

30 Participants Needed

Trial Summary

What is the purpose of this trial?

This study aims to assess the feasibility, acceptability, and safety of using ReCognitionVR virtual reality-based software in older surgical patients. Results from this study will be used to inform the design of a future study in critically ill hospitalized patients at risk for delirium.

Research Team

Hina Faisal, MD

Principal Investigator

The Methodist Hospital Research Institute

Eligibility Criteria

This trial is for older patients who have recently undergone surgery and are at risk of developing delirium, a state of confusion. Participants must be able to give consent and follow study procedures. Those with conditions that may interfere with the use of virtual reality or increase risks, such as severe visual impairment or motion sickness, cannot join.

Inclusion Criteria

I am scheduled for a specific type of abdominal surgery.

I am calm and alert, with no agitation or sedation.

I am 60 years old or older.

Exclusion Criteria

Subjects with baseline cognitive impairment

I am currently being treated for a psychiatric disorder, such as schizophrenia.

I am deaf or blind.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive cognitive exercises using either traditional orientation methods or ReCognitionVR virtual reality software

Up to 2 hours per session

1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessment of treatment-emergent adverse events

1 month

Treatment Details

Interventions

• ReCognitionVR

Trial Overview The study is testing how practical and acceptable it is to use ReCognitionVR software for cognitive stimulation compared to traditional methods in post-surgery care. It's a preliminary step before a larger trial on preventing delirium in critically ill patients.

Participant Groups

Group I: Virtual Reality Software Experimental Treatment 1 Intervention

Participants in this arm will receive cognitive exercises using ReCognitionVR virtual reality software

Group II: Traditional Orientation Methods Active Control 1 Intervention

Participants in this arm will receive cognitive exercises using traditional (standard-of-care) orientation methods,

Who Is Running the Clinical Trial?

The Methodist Hospital Research Institute

Lead Sponsor

Trials

299

Recruited

82,500+

National Institute on Aging (NIA)

Collaborator

Trials

1,841

Recruited

28,150,000+